Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 22, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	5,929	3,575	514	95	70	73
Market Cap Growth	340.79%	595.01%	443.89%	35.73%	-4.81%	27.91%
Enterprise Value	5,776	3,504	520	199	165	135
Last Close Price	13.54	8.03	1.15	0.31	0.23	0.24
PE Ratio	72.33	19.28	11.67	12.60	37.04	205.58
PS Ratio	17.75	4.68	0.87	0.46	0.62	0.62
PB Ratio	10.92	6.20	2.03	0.58	0.45	0.48
P/TBV Ratio	10.92	6.20	2.03	0.58	0.45	0.48
P/FCF Ratio	-	-	-	1.47	-	-
P/OCF Ratio	-	-	16.23	1.18	12.97	6.14
EV/Sales Ratio	17.29	4.58	0.88	0.97	1.47	1.14
EV/EBITDA Ratio	44.31	16.18	8.01	6.78	9.38	8.75
EV/EBIT Ratio	53.36	17.87	11.17	15.63	58.82	216.80
EV/FCF Ratio	-	-	-	3.09	-	-
Debt / Equity Ratio	0.05	0.06	0.20	0.21	0.63	0.52
Debt / EBITDA Ratio	0.21	0.15	0.78	1.15	5.57	5.23
Debt / FCF Ratio	-	-	-	0.52	-	-
Asset Turnover	-	1.00	1.08	0.58	0.32	0.38
Inventory Turnover	-	16.28	12.78	3.73	1.81	3.62
Quick Ratio	-	2.89	1.00	0.62	1.46	1.34
Current Ratio	-	3.97	1.25	1.28	2.28	2.07
Return on Equity (ROE)	-	44.70%	21.16%	4.70%	1.21%	0.23%
Return on Assets (ROA)	-	16.04%	5.29%	2.25%	0.51%	0.13%
Return on Capital (ROIC)	13.07%	26.88%	11.62%	3.53%	0.72%	0.17%
Return on Capital Employed (ROCE)	-	30.80%	14.40%	5.60%	1.00%	0.20%
Earnings Yield	1.38%	5.19%	8.57%	7.94%	2.70%	0.49%
FCF Yield	-	-1.95%	-2.57%	68.08%	-18.00%	-26.77%
Dividend Yield	0.72%	1.24%	1.09%	4.06%	-	-
Payout Ratio	-	0.38%	1.65%	-	-	-
Buyback Yield / Dilution	-25.21%	-551.03%	-7.38%	-	-0.02%	-
Total Shareholder Return	-24.50%	-549.78%	-6.29%	4.06%	-0.02%	-

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.